Mahsa Tehrani
Dr. Mahsa Tehrani is a rheumatologist known for her expertise in the field of autoimmune diseases and her commitment to advancing medical knowledge through research and patient education. She recently shared strategies for preventing Parkinson's disease, highlighting the importance of addressing the projected surge in cases by 2050, as indicated by a new study that predicts a significant increase in global prevalence of the neurological disorder.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 3 | 7.00 | 0.12% | +20% | 331,002,651 | 474,745 | $21,000,000 | 30,120$ |
| Totals | 3 | 331,002,651 | 474,745 | $21,000,000 | 30,120$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Dr. Mahsa Tehrani, a board-certified rheumatologist, joins ‘America Reports’ to break down a new study on the connection between the artificial sweetener Splenda and hunger.
7
United States:
Dr. Mahsa Tehrani discusses how weight training could reduce the risk of dementia on ‘America Reports.’
7
United States:
Mahsa Tehrani discusses how weight training could reduce the risk of dementia on ‘America Reports.’
7
United States:
Board certified rheumatologist Dr. Mahsa Tehrani discusses treating high blood pressure on 'America Reports.'
7
United States:
Dr. Mahsa Tehrani discusses how patients use medication to help them lose weight on 'America Reports.'
8
United States:
Dr. Mahsa Tehrani discusses how weight training could reduce the risk of dementia on ‘America Reports.’
7
United States:
Dr. Mahsa Tehrani discusses President Donald Trump’s possible 25% tariff on overseas medication and a new study on the relationship between Ozempic and dementia risk.
6
United States:
Rheumatologist Dr. Mahsa Tehrani shares strategies for preventing what a new study projects will be a prevalence of Parkinson's disease on 'America Reports.'
7
United States:
Dr. Mahsa Tehrani joins ‘America Reports’ to break down a new study on the connection between the artificial sweetener Splenda and hunger.
7
United States:
Dr. Mahsa Tehrani discusses President Donald Trump’s possible 25% tariff on overseas medication and a new study on the relationship between Ozempic and dementia risk.
7